Premium KLOW 80MG Research Peptide Blend — Quad‑Compound Synergistic Formulation for Laboratory Use

Product Overview

Premium KLOW 80MG is a research‑grade multi‑peptide blend combining four complementary regenerative peptides in a single lyophilized formulation. It is supplied as a sterile lyophilized powder in sealed vials. Each package contains ten vials, with each vial containing a precise combination of GHK‑Cu, BPC‑157, TB‑500, and KPV. This product is manufactured exclusively for scientific investigation and in vitro laboratory experimentation.

Key Specifications at a Glance:

• Quantity: 80mg total per vial, 10 vials per pack

• Composition: GHK‑Cu (50mg), BPC‑157 (10mg), TB‑500 (10mg), KPV (10mg)

• Form: Lyophilized (freeze‑dried) powder

• Purity: ≥99% verified by third‑party testing

• Research Focus: Multi‑pathway tissue repair, angiogenesis, inflammation modulation, extracellular matrix remodeling

• Research Use Only: Not for human or animal consumption

Understanding KLOW 80MG: The Research Context

KLOW 80MG is a pre‑formulated peptide stack designed for laboratory research into systemic tissue regeneration and repair mechanisms. Unlike single‑peptide protocols that target isolated pathways, KLOW addresses multiple complementary biological processes simultaneously, reflecting the understanding that tissue healing requires coordinated activity across inflammation resolution, angiogenesis, cellular migration, and structural remodeling.

The Four Components of KLOW 80MG:

The Systems Biology Principle Behind KLOW:
Tissues heal through coordinated parallel processes, not isolated steps. Inflammation resolution, angiogenesis, cellular repair, and remodeling occur simultaneously. Supporting only one of these processes creates imbalance and may delay recovery. KLOW was engineered to support four essential pillars of regeneration at the same time: structural rebuilding (GHK‑Cu), repair signaling (BPC‑157), cellular migration (TB‑500), and immune modulation (KPV).

Component Profiles: The Four Peptides

GHK‑Cu (50mg) — The Copper Peptide for Extracellular Matrix Remodeling

GHK‑Cu is a naturally occurring copper‑binding tripeptide (Gly‑His‑Lys) that has been extensively studied for its role in gene expression modulation and tissue remodeling. Within KLOW, GHK‑Cu provides the structural reinforcement that converts short‑term healing into long‑term tissue resilience.

Key Research Interests:

• Stimulates collagen and elastin synthesis

• Modulates approximately 31% of human genes with ≥50% expression changes

• Activates antioxidant defense pathways

• Supports angiogenesis and ECM organization

BPC‑157 (10mg) — The Body Protection Compound for Repair Signaling

BPC‑157 is a synthetic pentadecapeptide derived from a gastric protein, known for its cytoprotective and angiogenic properties. Within KLOW, BPC‑157 functions as a repair initiator, promoting blood flow and creating metabolic conditions necessary for regeneration.

Key Research Interests:

• Promotes angiogenesis through VEGF activation

• Enhances nitric oxide signaling

• Accelerates tendon, ligament, and muscle healing models

• Protects gastrointestinal barrier integrity

TB‑500 (10mg) — The Thymosin Beta‑4 Fragment for Cellular Migration

TB‑500 is a synthetic fragment of thymosin beta‑4 (Ac‑LKKTETQ), known for its actin‑binding and cell‑motility properties. Within KLOW, TB‑500 ensures that repair cells arrive at the correct location and organize into functional tissue.

Key Research Interests:

• Binds G‑actin and regulates cytoskeletal dynamics

• Promotes endothelial cell migration and angiogenesis

• Reduces dysfunctional scarring

• Supports tissue remodeling and organization

KPV (10mg) — The Anti‑Inflammatory Tripeptide for Immune Modulation

KPV is a synthetic tripeptide (Lys‑Pro‑Val) corresponding to the C‑terminal fragment of α‑MSH, studied for its anti‑inflammatory properties independent of melanocortin receptors. Within KLOW, KPV modulates inflammatory responses to create a favorable environment for tissue repair.

Key Research Interests:

• Inhibits NF‑κB activation via IκB‑α stabilization

• Reduces pro‑inflammatory cytokines (TNF‑α, IL‑1β, IL‑6)

• Enters cells via PepT1 transporter

• Modulates macrophage and immune cell activation

Third‑Party Testing and Quality Assurance

Every batch of Premium KLOW 80MG undergoes rigorous independent analytical testing to verify identity, purity, and consistency. This third‑party testing ensures that researchers receive a product that meets strict quality specifications before it is approved for release.

The testing process includes:

• Identity verification through mass spectrometry for each component

• Purity analysis using high‑performance liquid chromatography (HPLC)

• Batch‑to‑batch consistency checks

• Endotoxin testing to confirm sterility

• Residual solvent analysis to confirm complete lyophilization

With a verified purity of ≥99%, KLOW 80MG meets the high standards required for serious laboratory research applications. Each vial contains only the lyophilized research compound combination with no unnecessary additives, fillers, or excipients. Batch‑specific Certificates of Analysis (CoA) are available upon request.

Chemical and Physical Properties

Molecular Characteristics of Each Component

Physical Form and Storage

The product is supplied as a lyophilized (freeze‑dried) powder within a sterile, sealed vial. The blend appears as a homogeneous, off‑white to pale blue substance due to the copper content of GHK‑Cu.

Recommended Storage Conditions:

• Store lyophilized powder at -20°C (-4°F) or below for long‑term preservation

• Protect from light exposure

• Keep desiccated to prevent moisture absorption

• Allow vial to reach room temperature before opening to avoid condensation

• Avoid repeated freeze‑thaw cycles once reconstituted

Stability and Reconstitution Notes:
Research has demonstrated that GHK‑Cu remains stable at neutral pH. BPC‑157 is known to survive extreme acidic conditions (pH 1.5‑3.5), making neutral conditions well within its stability profile. Under proper storage conditions (refrigerated, protected from light and agitation), the blended formulation remains stable for extended research use.

Once reconstituted with an appropriate sterile solvent, the solution should be used according to laboratory protocols, typically within 30 days when stored refrigerated at 2‑8°C.

Intended Use and Regulatory Status

Research Use Only

KLOW 80MG is classified as a research chemical and is intended exclusively for laboratory and in vitro experimentation. This designation means the product is sold strictly for:

• In vitro testing — experiments conducted in controlled laboratory environments

• Cell culture studies — investigating multi‑peptide interactions with cellular systems

• Tissue repair research — studying coordinated regenerative pathways

• Angiogenesis studies — investigating blood vessel formation mechanisms

• Inflammation research — studying NF‑κB and cytokine modulation

• Analytical research — chemical analysis and characterization studies

• Scientific investigation — basic research into multi‑peptide formulations

Important Regulatory Notice

This product is not a drug, food, cosmetic, or medical device. Bodily introduction of any kind into humans or animals is strictly forbidden by law. The product should only be handled by licensed, qualified professionals working in appropriate laboratory facilities.

The supplier is a chemical supplier, not a compounding pharmacy or outsourcing facility under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act. All product information provided is for educational and research purposes only and does not constitute medical advice or clinical recommendations.

Handling and Safety Guidelines

Professional Handling Required

KLOW 80MG should only be handled by trained laboratory personnel wearing appropriate personal protective equipment (PPE), including:

• Laboratory coat

• Nitrile gloves

• Safety goggles or face shield

• Appropriate respiratory protection if aerosolization is possible

Reconstitution Protocol

For laboratory use, the lyophilized powder should be reconstituted with a sterile, compatible solvent. Standard practice includes:

1. Allow the sealed vial to reach room temperature — approximately 15-30 minutes

2. Clean the rubber stopper with an alcohol swab

3. Add 3.0 mL of bacteriostatic water (or appropriate sterile solvent) slowly down the vial wall

4. Gently swirl or roll the vial between palms — do not shake vigorously to avoid foaming

5. Allow complete dissolution before use — this typically takes 5‑10 minutes

Reconstitution Results with 3.0 mL solvent:

• Total concentration: ~26.7 mg/mL

• GHK‑Cu concentration: ~16.7 mg/mL

• BPC‑157 concentration: ~3.33 mg/mL

• TB‑500 concentration: ~3.33 mg/mL

• KPV concentration: ~3.33 mg/mL

For alternative reconstitution volumes, researchers should calculate concentrations based on their specific experimental requirements.

Solvent Considerations:
Sterile bacteriostatic water (pH 5.5‑7.0) is the recommended reconstitution vehicle. The benzyl alcohol in bacteriostatic water prevents bacterial growth during the typical 30‑day research use window. Under refrigerated conditions with proper handling, the reconstituted blend maintains stability.

Disposal Considerations

Dispose of KLOW 80MG and any contaminated materials in accordance with federal, state, and local regulations for chemical waste disposal. Do not dispose of in regular trash or down drains unless permitted by local guidelines.

Research Applications

KLOW 80MG is used in various laboratory research contexts, enabling investigators to study multiple pathways simultaneously. Typical applications include:

Tissue Repair and Regeneration Studies:

• Collagen deposition and extracellular matrix remodeling

• Fibroblast migration and activation

• Wound healing kinetics in controlled models

Angiogenesis and Vascular Research:

• Endothelial cell migration and proliferation

• Growth factor expression (VEGF, bFGF)

• Capillary formation and vascular density

Musculoskeletal Injury Models:

• Tendon and ligament repair mechanisms

• Connective tissue healing dynamics

• Muscle regeneration and recovery

Inflammatory Pathway Investigations:

• NF‑κB signaling modulation

• Cytokine and chemokine expression profiles

• Macrophage polarization and activation

Cell Culture Investigations:

• Cellular responses to multi‑peptide stimulation

• Gene expression changes following treatment

• Cell viability and proliferation under various conditions

• Comparative mechanism research between single and combined peptides

Researchers should design their experimental protocols based on peer‑reviewed literature and established laboratory practices specific to multi‑peptide formulations.

What Makes This Product Different

Pre‑Formulated Quad‑Peptide Synergistic Blend

Unlike individual research peptides that require separate handling, reconstitution, and combination, KLOW combines four complementary peptides into a single vial at optimized ratios. This structured approach supports consistency, efficiency, and reproducibility in peptide‑focused research settings.

Systems‑Based Research Design

KLOW was engineered based on systems biology principles rather than isolated pathway targeting. By addressing copper‑mediated ECM activation (GHK‑Cu), cytoprotective signaling (BPC‑157), actin‑dependent cell motility (TB‑500), and immune modulation (KPV) simultaneously, KLOW allows researchers to study coordinated tissue regeneration. KLOW 80MG

Optimal Ratios for Research

The specific ratio of GHK‑Cu (50mg), BPC‑157 (10mg), TB‑500 (10mg), and KPV (10mg) reflects the different effective concentration ranges of each peptide, providing a balanced formulation for multi‑pathway studies. KLOW 80MG

Rigorous Quality Control

Unlike research chemicals sold without verification, KLOW 80MG comes with documented third‑party testing for every batch, including HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing. KLOW 80MG

Batch Traceability

Each package of KLOW 80MG includes batch identification numbers that allow researchers to trace their material back to original manufacturing and testing records. This traceability is essential for reproducible research and quality documentation.

Frequently Asked Questions for Researchers

What is the composition of KLOW 80MG?

KLOW contains four research peptides: GHK‑Cu (50mg), BPC‑157 (10mg), TB‑500 (10mg), and KPV (10mg) for a total of 80mg per vial. KLOW 80MG

What is the purity level of KLOW 80MG?

Each batch is tested to verify purity of ≥99% for each component via HPLC, with identity confirmed by mass spectrometry. Individual certificates of analysis are available upon request.

What is the significance of the pale blue color?

The pale blue tint of the lyophilized powder is characteristic of GHK‑Cu, which contains copper and naturally appears blue to blue‑green.

How should the lyophilized powder be stored?

Store at -20°C or below, protected from light and moisture. Avoid repeated freeze‑thaw cycles once reconstituted. The lyophilized powder has a shelf life of approximately 24 months when stored properly. KLOW 80MG

What solvent should be used for reconstitution?

The standard protocol recommends 3.0 mL of bacteriostatic water. Researchers should determine the appropriate solvent based on their specific experimental protocol. KLOW 80MG

Is this product sterile?

The lyophilized powder is manufactured under aseptic conditions. Researchers should follow standard laboratory practices for handling research chemicals. For cell culture applications, additional filtration using a 0.22‑micron filter may be appropriate. KLOW 80MG

What research applications is KLOW 80MG used for?

KLOW is studied in tissue regeneration research, wound healing models, angiogenesis studies, musculoskeletal repair, and inflammatory pathway investigations in laboratory cell cultures.

Can KLOW 80MG be used in combination with other research reagents?

Researchers should determine compatibility based on their specific experimental design. Standard laboratory practice includes testing interactions in control experiments before full‑scale implementation. KLOW 80MG

Final Notes for Laboratory Researchers

Premium KLOW 80MG represents a high‑purity research tool for qualified professionals conducting legitimate scientific investigations into multi‑pathway tissue regeneration, angiogenesis, cellular migration, inflammation modulation, and related regenerative medicine fields. With documented third‑party testing, complete chemical specifications, and appropriate packaging for laboratory use, this product meets the standards expected by serious researchers.

The pre‑formulated quad‑peptide blend offers researchers the ability to study complementary mechanisms simultaneously, including copper‑mediated extracellular matrix activation (GHK‑Cu), cytoprotective signaling and angiogenesis (BPC‑157), actin‑dependent cell motility and tissue organization (TB‑500), and NF‑κB‑mediated anti‑inflammatory modulation (KPV).

For research use only. Not for human or animal consumption. Handle only in appropriate laboratory facilities with proper safety equipment and training.